A review of the trends of lymphomas in the equatorial belt of Africa†‡
Emily A. Rogena
Department of Human Pathology and Oncology, University of Siena, Siena, Italy
Department of Pathology, University of Nairobi, Nairobi, Kenya
Search for more papers by this authorGiulia De Falco
Department of Human Pathology and Oncology, University of Siena, Siena, Italy
Search for more papers by this authorKarin Schurfeld
Department of Human Pathology and Oncology, University of Siena, Siena, Italy
Pathologic Anatomy Asl8, Montevarchi, Siena, Italy
Search for more papers by this authorCorresponding Author
Lorenzo Leoncini
Department of Human Pathology and Oncology, University of Siena, Siena, Italy
Department of Human Pathology and Oncology, University of Siena, Via delle Scotte, 6–53100 Siena, Italy.Search for more papers by this authorEmily A. Rogena
Department of Human Pathology and Oncology, University of Siena, Siena, Italy
Department of Pathology, University of Nairobi, Nairobi, Kenya
Search for more papers by this authorGiulia De Falco
Department of Human Pathology and Oncology, University of Siena, Siena, Italy
Search for more papers by this authorKarin Schurfeld
Department of Human Pathology and Oncology, University of Siena, Siena, Italy
Pathologic Anatomy Asl8, Montevarchi, Siena, Italy
Search for more papers by this authorCorresponding Author
Lorenzo Leoncini
Department of Human Pathology and Oncology, University of Siena, Siena, Italy
Department of Human Pathology and Oncology, University of Siena, Via delle Scotte, 6–53100 Siena, Italy.Search for more papers by this authorEAR and GDF wrote the paper, KS conducted epidemiological studies, LL coordinated the study. The Authors declare that there are no conflicts of interest. Study was funded by Fondazione Monte Paschi Siena, Italy.
No duplicate publication or submission elsewhere of any part of the work has been performed.
Abstract
Lymphomas represent one of the most frequent cancer types in Africa. In particular, approximately 30 000 non-Hodgkin lymphomas occur in the equatorial belt of Africa each year and these tumours are in among the top-ten cancers in this geographical region. Several pathogens and environmental factors have been detected in association with these tumours, suggesting that they may contribute to lymphomagenesis. Unfortunately, there are still striking differences between developed and African countries in terms of early detection, diagnosis and treatment of lymphomas. Of note, the disease burden appears to be increasing in Africa. In addition, a much lower cure rate in the low-income countries suggests that the difference in mortality will even become more pronounced in future. Therefore, improving diagnosis is crucial as without it, neither meaningful research projects nor effective patient management can be instituted. In this review, we will summarize the state-of-the-art of lymphoma epidemiology, pathobiology and therapy, and will highlight the still existing gaps between developed and African countries. Copyright © 2010 John Wiley & Sons, Ltd.
References
- 1 World Health Organization Classification of Tumours: Tumours of Haematopoietic, Lymphoid tissues, ES Jaffe, NL Harris, H Stein, JW Vardimar (eds). IARC Press: Lyon, 2008; 262–264.
- 2Grulich AE, Vajdic CM. The epidemiology of non-Hodgkin lymphoma. Pathology 2005; 37: 409–419.
- 3Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 2006; 107: 265–276.
- 4Rasti N, Falk KI, Donati D, et al. Circulating Epstein-Barr virus in children living in malaria-endemic areas. Scand J Immunol 2005; 61: 461–465.
- 5Moormann AM, Chelimo K, Sumba OP, et al. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 2005; 191: 1233–1238.
- 6Mutalima N, Molyneux E, Jaffe H, et al. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a Case–Control Study. Creativecommons.org/licenses/by/2.5/13-04-09.
- 7Rainey JJ, Omenah D, Sumba PO. Spatial clustering of endemic Burkitt's lymphoma in high-risk regions of Kenya. Int J Cancer 2006; 120: 121–127.
- 8Leoncini L, Raphael M, Stein H, et al. Burkitt Lymphoma. World Health Organization Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues. In World Health Organization classification of tumours: tumours of haematopoietic and lymphoid tissues ES Jaffe, NL Harris, H Stein, JW Vardimar (eds). IARC Press: Lyon, 2008; 262–264.
- 9Angeletti PC, Zhang L, Wood C. The viral etiology of AIDS-associated malignancies. Adv Pharmacol 2008; 56: 509–557.
- 10Levine AM. AIDS-related lymphoma. Semin Oncol Nurs 2006; 22: 80–89.
- 11Noy A. Update in HIV lymphoma. Curr Opin Oncol 2006; 18: 449–455.
- 12Pantanowitz L, Schlecht HP, Dezube BJ. The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol 2006; 18: 469–478.
- 13Wood C, Harrington W Jr. AIDS and associated malignancies. Cell Res 2005; 15: 947–952.
- 14Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865–1869.
- 15Chang Y, Moore PS. Kaposi's sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis 1996; 5: 215–222.
- 16Ho M, Webster HK, Green B, Looareesuwan S, Kongchareon S, White NJ. Defective production of and response to IL-2 in acute human falciparum malaria. J Immunol 1998; 141: 2755–2759.
- 17Westergaard T, Andersen PK, Pedersen JB, et al. Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst 1997; 89: 939–947.
- 18Thiede C, Wündisch T, Alpen B, et al. German MALT Lymphoma Study Group. Persistance of monoclonal B Cells after eradication of H. pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 2001; 19: 1600–1609.
- 19Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Lumbroso-Le Rouic L. Ocular adnexal lymphoma: a review of clinicopathological features and treatment options. Blood 2006; 108: 1451–1460.
- 20Du MQ, Isaacson PG. Gastric MALT lymphomas: from aetiology to treatment. Lancet Oncol 2002; 3: 97–104.
- 21Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4: 644.
- 22Akpek EK, Polcharoen W, Chan R, Foster CS. Ocular surface neoplasia masquerading as chronic blepharoconjunctivitis. Cornea 1999; 18: 282–288.
- 23Mannami T, Yoshino T, Oshima K, et al. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of MALT lymphoma and reactive lymphoid hyperplasia. Mod Pathol 2001; 14: 641–649.
- 24Lee DH, Sohn HW, Park SH, Kang YK. Bilateral conjunctival mucosa-associated lymphoid tissue lymphoma misdiagnosed as allergic conjunctivitis. Cornea 2001; 20: 427–429.
- 25Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphoma. J Natl Cancer Inst 2004; 96: 586–594.
- 26Ferreri AJ, Ponzoni M, Guidoboni M, et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 2005; 23: 5067–5073.
- 27Ferreri AJ, Dolcetti R, Dognini GP, et al. Chlamydophila psittaci is viable and infectious in the conjubctiva and peripheral blood of patients with ocular adnexal lymphoma: results of a single-center prospective case-control study. Int J Cancer 2008; 123: 1089–1093.
- 28Rosado MF, Byrne GE Jr, Ding F, et al. Ocular adnexal lymphoma: a clinicopathological study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 2006; 107: 467–472.
- 29Chanudet E, Zhou Y, Bacon CM, et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol 2006; 209: 344–351.
- 30Aigelsreiter A, Leitner E, Deutsch AJA, et al. Chlamydia psittaci in MALT lymphomas of ocular adnexals: the Austrian experience. Leukemia Res 2008, 32: 1292–1294.
- 31Vargas RL, Fallone E, Felgar RE, et al. Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience. Leukemia Res 2006; 30: 547–551.
- 32Fisher SG, Fisher RI. The epidemiology of non-Hodgkins lymphoma. Oncogene 2004; 23: 6524–6534.
- 33Glennhard AH, Maina TM. Reversing the trend of weak policy implementation in the Kenyan health sector – a study of budget allocation and spending of health resources versus set priorities. Policy system 2007; 5: 1478–4505.
- 34Wamai RG. The Kenia Health System – analysis of the situation and enduring challenges. JMAJ 2009; 52: 134–140.
- 35Emote CE, Enosolease ME. The effect of accessibility to drugs on the outcome of therapy in patients with malignant lymphoma. Niger Postgrad Med J 2008; 15: 10–14.
- 36Stefan DC, Stones D, Dippenaar A, Kidd M. Ethnicity and the characteristics of Hodgkin lymphoma in children. Pediatr Blood Cancer 2009; 52: 153–154.
- 37Neal RD, Allgar VL. Sociodemographic factors and delays in diagnosis of six cancers: analysis of data form the ‘National survey of NHS Patients: cancer’. Br J cancer 2005; 92: 1971–1975.
- 38Ribeiro RC, Pui CH. Saving the children – improving childhood cancer treatment in developing countries. N Engl J Med 2005; 352: 2158–2160.
- 39Burton A. The UICC my child matters initiative awards: combating cancer in children in the developing world. Lancet Oncol 2006; 7: 13–14.
- 40Ribeiro RC, Steliarova-Foucher E, Magrath I. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters Support: a descriptive study. Lancet Oncol (thelancet.com) 2008; 9: 721–729.
- 41Orem J, Mbidde EK, Weiderpass E. Current investigations and treatment of Burkitt's lymphoma in Africa. Trop doct 2008; 38: 7–11.
- 42Cavalli F. Cancer in the developing world: can we avoid the disaster? Nat clin pract oncol 2006; 3: 582–583.